Statement of Retraction. EGFR Tyrosine Kinase Inhibitor...

  • Main
  • 2017 / 04
  • Statement of Retraction. EGFR Tyrosine Kinase Inhibitor...
Diabetes 2017 / 04

Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice. Diabetes 2009;58:2910–2919. DOI: 10.2337/db08-0506. PMID: 19696185

Prada, Patricia O., Ropelle, Eduardo R., Mourão, Rosa H., de Souza, Claudio T., Pauli, Jose R., Cintra, Dennys E., Schenka, André, Rocco, Silvana A., Rittner, Roberto, Franchini, Kleber G., Vassallo,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Diabetes
DOI:
10.2337/db17-rt07a
Date:
April, 2017
File:
PDF, 440 KB
english, 2017
Conversion to is in progress
Conversion to is failed